THE WORLD'S TOP 100 INNOVATION LEADERS OF 2022 - WORLD BIZ MAGAZINE AWARDS
Top 100 Innovation Leaders of 2022
Now in the fifth year, the annual World Biz Magazine Leadership Awards celebrates business leaders across the globe that are making major strides in their industries.
The WBM Top 100 Innovation Leaders Awards recognizes product, service, functional, strategic, and managerial innovation in companies. The Awards also recognizes individuals showing exceptional commercial insight and market integrity. Sustainability forms a key cornerstone of the Awards and is an integral part of our selection criteria.
This year there were over 40,000 leaders shortlisted for the Awards. There are only 100 CEOs across the world selected to receive this distinction. Winners were selected regardless of the size of company they lead, the most important determining factor being their role in driving innovation within their industry.
Only 0.25% of the shortlisted leaders have been selected by our researchers and independent judges for this recognition. We are honored to share this showcase of our deserving Award Winners with you.
Dr. Severin Schwan, Chief Executive Officer of Roche Group is at 1st place on the 2022 list of Top 100 Innovation Leaders.
Dr. Severin Schwan
Chief Executive Officer
Dr. Severin Schwan has been the Chief Executive Officer of Roche Group since 2008. He earned his degree in Economics at the University of Innsbruck, University of York and University of Oxford, Mag. rer.soc.oec. (Innsbruck, 1991). He also studied Law at the University of Innsbruck, Mag. iur. (Innsbruck, 1991). He earned his Doctorate in Law at the University of Innsbruck, Research studies at University Louvain, Belgium, Dr. iur. (Innsbruck, 1993).
Dr. Schwan is a member of the Board of Directors of Roche Holding Ltd. He is also a member of the Board of Directors (since 2017 Vice Chairman) of Credit Suisse Group AG. He is a member of the International Business Leaders Advisory Council for the Mayor of Shanghai (IBLAC), since 2022 he has been the Vice Chairman.
Throughout its 125-year history, Roche has grown into one of the world’s largest biotech companies, as well as a leading provider of in-vitro diagnostics and a global supplier of transformative innovative solutions across major disease areas. Its commitment to its people, partners, stakeholders and, most importantly, its patients remains as strong as it was on the first day of the company's journey.
For more information about Roche, visit: roche.com
Dr. Lisa T. Su, Chair and Chief Executive Officer of AMD is at 2nd place on the 2022 list of Top 100 Innovation Leaders.
Dr. Lisa T. Su
Chair and Chief Executive Officer
Dr. Lisa T. Su is chair and chief executive officer of AMD. Prior to serving as president and CEO, she was chief operating officer responsible for integrating AMD’s business units, sales, global operations and infrastructure enablement teams into a single market-facing organization responsible for all aspects of product strategy and execution. Dr. Su joined AMD in January 2012 as senior vice president and general manager, global business units and was responsible for driving end-to-end business execution of AMD products and solutions.
Prior to joining AMD, Dr. Su served as senior vice president and general manager, Networking and Multimedia at Freescale Semiconductor, Inc. (a semiconductor manufacturing company) and was responsible for global strategy, marketing and engineering for the company’s embedded communications and applications processor business. Dr. Su joined Freescale in 2007 as chief technology officer, where she led the company’s technology roadmap and research and development efforts.
Dr. Su spent the previous 13 years at IBM in various engineering and business leadership positions, including vice president of the Semiconductor Research and Development Center responsible for the strategic direction of IBM’s silicon technologies, joint development alliances and semiconductor R&D operations. Prior to IBM, she was a member of the technical staff at Texas Instruments Inc. in the Semiconductor Process and Device Center from 1994 to 1995.
Dr. Su has bachelor’s, master’s and doctorate degrees in electrical engineering from the Massachusetts Institute of Technology (MIT). She has published more than 40 technical articles and was named a Fellow of the Institute of Electronics and Electrical Engineers in 2009. In 2018, Dr. Su was elected to the National Academy of Engineering and received the Global Semiconductor Association’s Dr. Morris Chang Exemplary Leadership Award. In 2020, Fortune named Dr. Su #2 on its “Business Person of the Year” list, she was elected to the American Academy of Arts & Science, and received the Grace Hopper Technical Leadership Abie Award. In 2021, she was recognized by the IEEE with its highest semiconductor honor, the Robert N. Noyce Medal and was appointed by President Biden to the President’s Council of Advisors on Science and Technology. She has been a member of the board of directors of Cisco Systems, Inc., since January 2020 and also serves on the board of directors for the Semiconductor Industry Association.
For more information about AMD, visit: amd.com
Dr. C. C. Wei, Chief Executive Officer of Taiwan Semiconductor Manufacturing is at 3rd place on the 2022 list of Top 100 Innovation Leaders.
Dr. C. C. Wei
Chief Executive Officer
Taiwan Semiconductor Manufacturing Company
Dr. C. C. Wei is Chief Executive Officer of Taiwan Semiconductor Manufacturing Co. Ltd. (TSMC). Prior to this appointment, Dr. Wei was TSMC's President and Co-CEO from November 2013 to June 2018 and Co-Chief Operating Officer from March 2012 to November 2013. From 2009 to 2012, he was TSMC's Senior Vice President of Business Development. Before that, Dr. Wei was Senior Vice President of Mainstream Technology Business.
Before joining TSMC in 1998, Dr. Wei had served as Senior Vice President of Technology at Chartered Semiconductor and Senior Manager, Logic and SRAM technology development at ST Microelectronics. Prior to that, he was a Member of Technical Staff at Texas Instruments R&D organization.
C. C. Wei received his B.S. degree in electrical engineering from National Chiao Tung University and Ph.D. from Yale University.
For more information about Taiwan Semiconductor Manufacturing Company, visit: tsmc.com
Ellen J. Kullman, Executive Chair of Carbon, Inc. is at 4th place on the 2022 list of Top 100 Innovation Leaders.
Ellen J. Kullman
Ellen is the Executive Chair of Carbon, previously serving as President & CEO. Prior to joining Carbon, Ellen was Chairman and CEO of DuPont. She was the nineteenth executive, and the first woman to lead the company in its 212-year history. As a business leader, Ellen led double-digit growth of the company’s Safety and Protection business portfolio, started two successful high-growth businesses known today as DuPont Industrial Biosciences and DuPont Sustainable Solutions. During her seven years as CEO, Ellen led the company’s focus on growth in emerging international markets and championed the power of DuPont science and global market knowledge to transform industries. She decisively positioned the company for its next generation of growth, executing a strong plan that is delivering results today while positioning DuPont for future growth.
Ellen is co-chair of the Paradigm for Parity coalition and a board director of Dell Technologies, Amgen, and Goldman Sachs. She is a member of the National Academy of Engineering and past president of the U.S. China Business Council. She serves on the board of trustees of Northwestern University. Ellen has been named as one of the “50 Most Powerful Women in Business” by Fortune and one of the “World’s Most Powerful Women” by Forbes. Ellen holds a B.S. in mechanical engineering from Tufts University and an MBA from the Kellogg School of Management of Northwestern University.
For more information about Carbon, visit: carbon3d.com
Gail Boudreaux, President and Chief Executive Officer of Elevance Health is at 5th place on the 2022 list of Top 100 Innovation Leaders.
Gail K. Boudreaux
President and Chief Executive Officer
Gail Boudreaux serves as president and chief executive officer at Elevance Health, where she leads the company in improving lives and communities, simplifying healthcare, and building trust with customers. Regarded for her ability to skillfully scale multi-billion-dollar businesses, Boudreaux leverages her more than three decades of healthcare industry experience to helm one of America’s largest health companies.
Fueled by our bold purpose to improve the health of humanity, Elevance Health is transforming from a traditional health benefits organization into a lifetime trusted health partner.
Our nearly 100,000 associates serve more than 118 million people, at every stage of health. We address a full range of needs with an integrated whole health approach, powered by industry-leading capabilities and a digital platform for health.
For more information about Elevance Health, visit: elevancehealth.com
Lee Yuan Siong, Group Chief Executive and President of AIA Group is at 6th place on the 2022 list of Top 100 Innovation Leaders.
Lee Yuan Siong
Executive Director and Group Chief Executive and President
Mr. Lee, aged 56, is an Executive Director and the Group Chief Executive and President of the Company, having been appointed on 1 June 2020. Mr. Lee is also a member of the Risk Committee of the Company. He joined the Group in March 2020 and has more than 30 years' experience in the insurance sector. He is a director of various companies within the Group including acting as Chairman and Chief Executive Officer of AIA Company Limited.
Prior to his current role, Mr. Lee was an executive director of Ping An Insurance (Group) Company of China, Ltd. from June 2013 and served as the company’s co-CEO and Chief Insurance Business Officer. Before joining Ping An, Mr. Lee held a number of senior leadership positions with Prudential plc of the United Kingdom, including President of CITIC-Prudential Life Insurance Company Limited, a life insurance joint venture in Mainland China. He also has significant experience across a number of Asian markets including Hong Kong SAR, India, Indonesia, Taiwan (China), Thailand and Vietnam.
Mr. Lee began his career at the Monetary Authority of Singapore. He has been a Director and appointed as Vice Chairman of The Geneva Association since November 2021. He has also been a member of the Hong Kong Academy of Finance since 2020. He holds a Master of Philosophy (Finance) degree from the University of Cambridge and is a Fellow of the Society of Actuaries (US).
For more information about AIA Group, visit: aia.com
Rosalind Brewer, Chief Executive Officer, Walgreens Boots Alliance, Inc. is at 7th place on the 2022 list of Top 100 Innovation Leaders.
Chief Executive Officer
Walgreens Boots Alliance
Rosalind (Roz) Brewer joined Walgreens Boots Alliance as Chief Executive Officer in March 2021. She also is a Director on WBA’s Board. Ms. Brewer most recently served as Chief Operating Officer and Group President at Starbucks from October 2017 to January 2021. Prior to Starbucks, she served as President and Chief Executive Officer of Sam’s Club, a membership-only retail warehouse club and division of Walmart, Inc., from February 2012 to February 2017. Ms. Brewer previously held several executive leadership positions with Walmart beginning in 2006.
Prior to joining Walmart, she served as President of Global Nonwovens Division for Kimberly-Clark Corporation, a global health and hygiene products company, from 2004 to 2006, and held various management positions at Kimberly-Clark beginning in 1984.
She currently serves as the Chairperson of the Board of Trustees for Spelman College, where she did her undergraduate work. Ms. Brewer also is a Board Member of VillageMD, World Business Chicago, Business Roundtable and the Smithsonian’s National Museum of African-American History and Culture. Ms. Brewer formerly served on the Board of Directors for Starbucks, Amazon, Lockheed Martin Corporation and Molson Coors Brewing Company. She is currently ranked #6 on Fortune’s 50 Most Powerful Women in Business and was named one of the 25 most influential women by the Financial Times in 2021.
For more information about Walgreens Boots Alliance, visit: walgreensbootsalliance.com
Sanjiv Lamba, Chief Executive Officer of Linde is at 8th place on the 2022 list of Top 100 Innovation Leaders.
Chief Executive Officer
Sanjiv Lamba is the Chief Executive Officer for Linde plc, in March 2022 he also joined the Board of Directors. Prior to being appointed CEO, Lamba was Chief Operating Officer after serving as Executive Vice President, APAC.
Lamba started his career in 1989 with BOC India in Finance, was appointed Director of Finance and subsequently Managing Director for the India business in 2001. He has worked in a number of geographies for Linde including India, UK, Singapore and Germany where he served as member of the Executive Board of Linde AG.
Lamba is a Chartered Accountant (Institute of Chartered Accountants of India) and holds a Bachelor of Commerce Degree (Honours) from St. Xavier’s College, Calcutta University, India.
For more information about Linde, visit: linde.com
Diane Wang, Founder, Chair and Chief Executive Officer of DHgate.com is at 9th place on the 2022 list of Top 100 Innovation Leaders.
Founder, Chairperson and Chief Executive Officer
Diane Wang, an original internet pioneer with over 20 years of experience running online businesses, has thrived through every phase of the digital revolution. Before founding DHgate, Ms. Wang co-founded and served as CEO of Joyo.com, which at the time was the largest B2C (Business-to-Consumer) online marketplace in China and eventually became Amazon China. Prior to Joyo.com, she held positions as an executive for Microsoft and Cisco.
Ms. Wang is also an active civil servant, she was appointed to serve on the APEC Business Advisory Council (ABAC) in recognition of her expertise and status as a leading advocate for the development of SMEs (Small-Medium-Enterprises) worldwide. Ms. Wang is the co-chair of the ABAC SME Working Group and Co-Chair of the APEC Women Leadership Forum. Ms. Wang is the first Rotating Chairperson of the Entrepreneurs Committee of the China SME Alliance. Ms. Wang also serves as the Chinese Representative to the G20 Business Summit (B20).
For more information about DHgate, visit: dhgate.com
Charles Brown, President and CEO of LifeLabs Medical Laboratory is at 10th place on the 2022 list of Top 100 Innovation Leaders.
President and Chief Executive Officer
LifeLabs Medical Laboratory
Charles Brown is President and CEO of LifeLabs Medical Laboratory, a leading Canadian-owned company that has been serving the healthcare needs of Canadians for more than 50 years. Each year LifeLabs performs approximately 120 million laboratory tests to help diagnose, treat, monitor and prevent diseases for millions of Canadians.
Charles is committed to the optimization of service delivery to provide better outcomes for customers, patients, medical professionals and the broader healthcare system. Since joining LifeLabs in 2018, he has worked to evolve LifeLabs into a commercially driven organization that brings customer-centred value to market. By showcasing the possibility of delivering value-based outcomes, Charles empowers his employees to make a difference and facilitate innovative change. During COVID-19, Charles’ leadership empowered the team to quickly pivot and adapt to respond to the pandemic by providing essential COVID-19 testing, while maintaining full operation of lab testing and diagnostic work.
Charles was named one of the Top 25 Biotechnology CEOs by the Healthcare Technology Report in 2021 and 2022. Charles was also nominated in 2022 by an external research team to receive the prestigious ‘Top Industry Leader’ award from Life Sciences Voice, being recognized amongst a list of distinguished leaders from BioPharma, BioTech, and related sectors.
For more information about LifeLabs Medical Laboratory, visit: lifelabs.com
Sasan Goodarzi, Chief Executive Officer of Intuit is at 11th place on the 2022 list of Top 100 Innovation Leaders.
Chief Executive Officer
Sasan Goodarzi is chief executive officer (CEO) of Intuit, where he leads the company towards delivering on its mission of powering prosperity around the world.
He assumed the role on Jan. 1, 2019. During his 14 years with the company, Goodarzi has successfully led each of Intuit’s largest businesses. Most recently, Goodarzi served as executive vice president and general manager of Intuit’s Small Business and Self-Employed Group. Previously, he served as executive vice president and general manager of Intuit’s Consumer Tax Group, as Intuit’s chief information officer, as the general manager of Intuit’s ProTax organization, and as the general manager of Intuit’s Financial Services Division.
Before coming to Intuit, Goodarzi worked for Invensys, a global provider of industrial automation, transportation and controls technology, serving as global president of the products group. He also held a number of senior leadership roles in the automation control division at Honeywell and served as the CEO and co-founder of a technology startup, Lazer Cables Inc.
Born in Tehran, Iran, Goodarzi came to the United States as a child and grew up in Orlando, Florida. He currently lives in the San Francisco Bay Area with his wife and two children. He earned his bachelor’s degree in electrical engineering at the University of Central Florida and a master’s in business administration from the Kellogg School of Management at Northwestern University. Goodarzi is also a member of the board of directors at Intuit and Atlassian.
For more information about Intuit, visit: intuit.com
Noel Quinn, Group Chief Executive of HSBC Bank is at 12th place on the 2022 list of Top 100 Innovation Leaders.
Group Chief Executive
Noel Quinn was appointed Group Chief Executive in March 2020, having previously served as interim Group Chief Executive from August 2019.
Mr Quinn has been with HSBC – or its constituent companies – since 1987, when he joined Forward Trust Group, a subsidiary of Midland Bank (now HSBC UK). He led HSBC’s acquisitions of Swan National Motor Finance and Eversholt Leasing Ltd, becoming General Manager of each business in turn. He subsequently served as Head of Specialised and Equity Finance at HSBC; Group Director of Strategy & Development at HSBC Insurance Services North America; Head of Commercial Finance Europe; and Head of Commercial Banking UK. From 2011 to 2015 he was the Regional Head of Commercial Banking for Asia-Pacific, based in Hong Kong.
Mr Quinn was appointed Chief Executive, Global Commercial Banking in December 2015. He became a Group Managing Director in September 2016. Mr Quinn qualified as an accountant in 1987.
For more information about HSBC, visit: hsbc.com
Patrick Gelsinger, Chief Executive Officer of Intel Corporation is at 13th place on the 2022 list of Top 100 Innovation Leaders.
Patrick (Pat) Gelsinger
Chief Executive Officer
Patrick (Pat) Gelsinger is chief executive officer of Intel Corporation and serves on its board of directors. On Feb. 15, 2021, Gelsinger returned to Intel, the company where he had spent the first 30 years of his career.
Before rejoining Intel, Gelsinger was CEO of VMware. In that role, he transformed VMware into a recognized global leader in cloud infrastructure, enterprise mobility and cyber security – almost tripling the company’s annual revenues. Gelsinger was also ranked the best CEO in America in 2019, according to an annual survey by Glassdoor. Prior to joining VMware in 2012, Gelsinger was president and chief operating officer of EMC’s Information Infrastructure Products business, overseeing engineering and operations for information storage, data computing, backup and recovery, RSA security and enterprise solutions.
Gelsinger began his career in 1979 at Intel, becoming its first chief technology officer, and also serving as senior vice president and the general manager of the Digital Enterprise Group. He managed the creation of key industry technologies such as USB and Wi-Fi. He was the architect of the original 80486 processor, led 14 microprocessor programs and played key roles in the Intel® Core™ and Intel® Xeon® processor families, leading to Intel becoming the preeminent microprocessor supplier.
Gelsinger earned several degrees in electrical engineering: an associate degree from Lincoln Technical Institute, a bachelor’s degree from Santa Clara University and a master’s degree from Stanford University. He holds eight patents in the areas of VLSI design, computer architecture and communications, is an IEEE Fellow, and serves as a member of the National Security Telecommunications Advisory Committee.
Gelsinger and his wife have been married for over 30 years; they have four children and eight grandchildren. He is also a published author and speaks frequently on faith, work and philanthropy.
For more information about Intel, visit: intel.com
Jensen Huang, Chief Executive Officer of NVIDIA is at 14th place on the 2022 list of Top 100 Innovation Leaders.
Founder, President and Chief Executive Officer
Jensen Huang founded NVIDIA in 1993 and has served since its inception as president, chief executive officer and a member of the board of directors.
Starting out in PC graphics, NVIDIA helped build the gaming market into the largest entertainment industry in the world today. The company’s invention of the GPU in 1999 made possible real-time programmable shading, which defines modern computer graphics, and later revolutionized parallel computing. More recently, GPU deep learning ignited modern AI — the next era of computing — with the GPU acting as the brain of computers, robots and self-driving cars that can perceive and understand the world.
Huang is a recipient of the Semiconductor Industry Association’s highest honor, the Robert N. Noyce Award; IEEE Founder’s Medal; the Dr. Morris Chang Exemplary Leadership Award; and honorary doctorate degrees from Taiwan’s National Chiao Tung University, National Taiwan University, and Oregon State University. He was included in TIME magazine’s 2021 list of the world’s 100 most influential people. In 2019, Harvard Business Review ranked him No. 1 on its list of the world’s 100 best-performing CEOs over the lifetime of their tenure. In 2017, he was named Fortune’s Businessperson of the Year.
Prior to founding NVIDIA, Huang worked at LSI Logic and Advanced Micro Devices. He holds a BSEE degree from Oregon State University and an MSEE degree from Stanford University.
For more information about NVIDIA, visit: nvidia.com
Michael Wu, Co-Founder and CEO of Amber Group is at 15th place on the 2022 list of Top 100 Innovation Leaders.
Co-Founder and Chief Executive Officer
Michael Wu is co-founder and CEO of Amber Group, a leading global digital asset company. Prior to founding Amber Group, Michael was a quantitative analyst at Goldman Sachs, a macro trader at Morgan Stanley, and a portfolio manager at a billion-dollar hedge fund. Michael is a member of Mensa International and a 2019 Forbes 30 Under 30 Asia honoree.
Founded in 2017, Amber Group is a leading global digital asset company operating globally with offices in Asia, Europe, and the Americas. Amber Group provides a full range of digital asset services spanning investing, financing, trading, and spending. Its 24/7 trading desk serves over a thousand institutional clients globally while the integrated digital asset platform WhaleFin serves the individual investors via mobile and desktop applications.
To date, Amber Group has raised a total of $328 million in funding from world-class investors including Temasek, Sequoia Capital, Paradigm, Tiger Global Management, Dragonfly Capital, Pantera Capital, Coinbase Ventures and Blockchain.com. Amber Group’s Series B + funding round of $200m valued the company at $3B.
For more information about Amber Group, visit: ambergroup.io
Ki Young Sohn, Chairman and CEO of Enzychem Lifesciences is at 16th place on the 2022 list of Top 100 Innovation Leaders.
Ki Young Sohn
Chairman and Chief Executive Officer
Ki Young Sohn is Chairman and CEO of Enzychem Lifesciences, a late-stage biotechnology company. With more than 30 years of experience in the life sciences and finance industry, Ki Young has previously led teams in various pharmaceutical settings to success. Most recently, he has led positive Phase 2 US results for Enzychem Lifesciences' lead candidate, EC-18 in Chemoradiation-induced Oral Mucositis (CRIOM) and execution of the partnership with Zydus Cadila to manufacture and distribute the world’s first COVID-19 pDNA vaccine.
Founded in 1999, Enzychem Lifesciences is developing novel small molecule therapeutics to target fundamental pathways in inflammation, for patients with unmet needs. Based on more than two decades of research, Enzychem developed its leading candidate EC-18, an oral small molecule derived from Sika deer antler, which has shown to be active across a number of different indications.
For more information about Enzychem Lifesciences, visit: enzychem.com
Jane Fraser, Chief Executive Officer of Citi is at 17th place on the 2022 list of Top 100 Innovation Leaders.
Chief Executive Officer
Jane Fraser is the Chief Executive Officer of Citi, the world's most global bank, serving millions of consumers, businesses and institutions across 160 countries and jurisdictions.
She is the first female CEO in the firm’s history. Jane has deep experience across Citi’s consumer and institutional businesses and, in many ways, she helped shape Citi into the company it is today. Before becoming CEO in February 2021, she was President of Citi and CEO of the Global Consumer Bank, responsible for all of Citi’s Consumer businesses, including Retail Banking and Wealth Management, Credit Cards, Mortgage and Operations and Technology in 19 markets. Before that, she was the Chief Executive Officer of Citigroup Latin America from 2015 to 2019. From 2013 to 2015, she was the Chief Executive Officer of the U.S. Consumer and Commercial Banking and CitiMortgage. From 2009 to 2013, Jane served as the Chief Executive Officer of Citi's Global Private Bank. Prior, Jane was the Global Head of Strategy and Mergers & Acquisitions for Citi from 2007 to 2009. She joined Citi in 2004 in the Corporate and Investment Banking division.
Before joining Citi, Jane was a Partner at McKinsey & Company. She started her career at Goldman Sachs in the Mergers & Acquisitions department in London and then worked for Asesores Bursátiles in Madrid, Spain. Jane serves as a Board Member for the Business Roundtable and the Council on Foreign Relations. She is Vice Chair for the Partnership for New York City and a member of Harvard Business School’s Board of Dean’s Advisors, the Stanford Global Advisory Board and the Economic Club of New York.
Jane has an M.B.A. from Harvard Business School and an M.A. in economics from Cambridge University. She is married with two children.
For more information about Citi, visit: citigroup.com
Hamutal Yitzhak, Chair and Chief Executive Officer of Else Nutrition is at 18th place on the 2022 list of Top 100 Innovation Leaders.
Chair and Chief Executive Officer
Else Nutrition Holdings
Hamutal Yitzhak is a successful serial entrepreneur and inventor, with a series of global patents and innovations to her name, coupled with a portfolio of novel innovative foods that are nutritious, nourishing and preventive.
Hamutal is the Chairwoman, CEO & Co-Founder of Else Nutrition Holdings Inc, which developed “Else” – the first 100% plant-based, globally patented dairy-free and soy-free baby nutrition, providing the first-ever viable alternative to traditional infant nutrition based on cow's milk and soy - which have been the standard for over 100 years. Else Nutrition was recently recognized by the TSX, a 2021 Venture 50TM Company, for best performance. Hamutal has dedicated most of her professional life to infant & child nutrition, and in recent years has relentlessly focused on the mission of making healthier cleaner foods accessible and available to everyone. In the last few years, Hamutal has been a trail blazer in this industry and has challenged the global infant formula industry by developing and producing natural clean foods, focusing on the transparency of ingredients and manufacturing processes to provide the cleanest and healthiest products possible.
Hamutal holds a BSc with honors in Psychology and General Science and MBA from Tel Aviv University. She lives in Tel Aviv, married and is a mother of 4.
For more information about Else Nutrition, visit: elsenutrition.com
Annica Bresky, President and Chief Executive Officer of Stora Enso is at 18th place on the 2022 list of Top 100 Innovation Leaders.
President and Chief Executive Officer
Annica Bresky is the President and Chief Executive Officer (CEO) of Stora Enso. Annica has been a member of the GLT since 2017. She joined the company in 2017, and has been President and CEO since 2019.
Previously Annica was EVP, Consumer Board Division 2017‒2019. President and CEO of Iggesund Paperboard AB, part of the Swedish Holmen Group 2013‒2017. Mill Director at BillerudKorsnäs AB 2010‒2013. Prior to that engineering and superintendent positions at Stora Enso’s Kvarnsveden Mill in 2001‒2010. Annica is a member of the Board of AB Fagerhult.
Part of the global bioeconomy, Stora Enso is a leading provider of renewable products in packaging, biomaterials, wooden construction and paper, and one of the largest private forest owners in the world. We believe that everything that is made from fossil-based materials today can be made from a tree tomorrow. Stora Enso has approximately 22,000 employees and our sales in 2021 were EUR 10.2 billion. Stora Enso shares are listed on Nasdaq Helsinki Oy (STEAV, STERV) and Nasdaq Stockholm AB (STE A, STE R). In addition, the shares are traded in the USA as ADRs (SEOAY).
For more information about Stora Enso, visit: storaenso.com
Christel Bories, Chairman and Chief Executive Officer of Eramet is at 20th place on the 2022 list of Top 100 Innovation Leaders.
Chairman and Chief Executive Officer
Christel Bories is Chairman and Chief Executive Officer of Eramet since 2017. Christel Bories began her career in 1986 as a strategy consultant with Booz-Allen & Hamilton before moving to Corporate Value Associates. She subsequently held several executive positions with Umicore, then Pechiney Group. Christel Bories was appointed Chairman and Chief Executive Officer of Alcan Packaging, then Chairman and Chief Executive Officer of Alcan Engineered Products and finally Chief Executive Officer of Constellium (ex Alcan), until December 2011. She was appointed Deputy Chief Executive Officer of Ipsen in February 2013 until March 2016. She also serves on the Board of Directors of Smurfit Kappa since 2012.
With operations in 20 countries around the world, Eramet is a major player in the beneficiation of ores and metals, as well as in the production and transformation of high-performance alloys. Fully committed to the energy transition, the Group aims to become a reference in the responsible transformation of the Earth’s mineral resources for living well together.
"Our goal is to continually drive value creation in all of our activities by being more agile, more effective and focused on areas where we will make a difference."
For more information about Eramet, visit: eramet.com
Pascal Soriot, Chief Executive Officer of AstraZeneca is at 21st place on the 2022 list of Top 100 Innovation Leaders.
Executive Director and Chief Executive Officer
Member of the Board and CEO since October 2012, Pascal brings a passion for science and medicine as well as significant experience in established and emerging markets, strength of strategic thinking, a successful track record of managing change and executing strategy, and the ability to lead a diverse organisation. He served as Chief Operating Officer of Roche’s pharmaceuticals division from 2010 to September 2012 and, prior to that, Chief Executive Officer of Genentech, a biologics business, where he led its successful merger with Roche. Pascal joined the pharmaceutical industry in 1986 and has worked in senior management roles in numerous major companies around the world. He is a doctor of veterinary medicine (École Nationale Vétérinaire d’Alfort, Maisons-Alfort) and holds an MBA from HEC, Paris.
Pascal received a British knighthood for services to UK life sciences and leadership in the global response to the COVID pandemic in the Queen’s Birthday Honours 2022.
For more information about AstraZeneca, visit: astrazeneca.com
Bernard Charlès, Chief Executive Officer of Dassault Systèmes is at 22nd place on the 2022 list of Top 100 Innovation Leaders.
Vice Chairman of the Board and Chief Executive Officer
Bernard Charlès has been working as the CEO of Dassault Systèmes since 1995 and as Vice Chairman of the Board of Directors since 2016. He started his career in the company in 1983 to develop new design technologies. In 1986, he founded a dedicated New Technologies, Research and Strategy department, and in 1988 was appointed President of Strategy, Research and Development.
Charlès has helped instill a culture of ongoing innovation to further consolidate Dassault Systèmes’ scientific capabilities and make science part of the company’s DNA. The inspiration behind digital mock-up, product lifecycle management and 3DEXPERIENCE®, he firmly believes that virtual technology is about making possible the impossible: 3DEXPERIENCE universes are the most powerful vehicle for testing concepts and creating the future, bringing dream and reality together, and stretching the limits of science and imagination to drive progress in society.
Charlès has positioned Dassault Systèmes as the preferred partner for sustainable innovation in three major sectors of the economy: Manufacturing Industries, Life Sciences & Healthcare, Infrastructure & Cities. The company, established in 1981 and world leader in virtual worlds, was recognized as one of Forbes’ "World’s Most Innovative Companies".
Bernard Charlès is a foreign member of the US National Academy of engineering and a member of the French Academy of Technology. He holds the rank of Commander in the “Légion d’honneur” (French Legion of Honor). He is a graduate of the Ecole Normale Supérieure engineering school in Cachan and has a PhD in mechanical engineering majoring in automation engineering and information science. He also holds an agrégation — the most senior teaching qualification achievable in France (specializing in mechanical engineering).
Alison Rose, Group Chief Executive of NatWest Group is at 23rd place on the 2022 list of Top 100 Innovation Leaders.
Group Chief Executive
Alison has been instrumental in leading NatWest Group’s progress and performance as a purpose-led organisation, since NatWest Group’s purpose was announced in February 2020.
Having gained a wealth of frontline banking experience during her 29-year career with NatWest, Alison brings a strong customer focus to Board discussions alongside an essential stakeholder lens. Alison is a passionate supporter of diversity and is executive sponsor for NatWest Group’s employee-led networks.
Having joined as a graduate in 1992, Alison’s diverse career at NatWest Group has included a number of senior leadership roles, including Deputy CEO of NatWest Holdings; Chief Executive of Commercial & Private Banking; Head of Europe, Middle East and Africa, Markets & International Banking; and Global Head of International Banking Capital and Balance Sheet.
In 2019, Alison was commissioned by the UK Government to report on the barriers to women starting businesses. She now sits on the Rose Review Board and is responsible for driving forward its recommendations.
Kristian Villumsen, President and CEO of Coloplast Group is at 24th place on the 2022 list of Top 100 Innovation Leaders.
President and Chief Executive Officer
Kristian Villumsen is the President and CEO of Coloplast Group. He has been with Coloplast since 2008. His previous responsibilities at Coloplast include: Senior Vice President, Global Marketing and Commercial Excellence, Senior Vice President - Europe Region, Senior Vice President - Emerging Markets, Executive Vice President - Chronic Care. He is a Board Member and Member of the Audit Committee of Demant A/S.
Kristian Villumsen holds a MA in Political Science from Aarhus University and a MA in Public Policy from Harvard University. He was born in 1970 and he is a Danish citizen.
Coloplast develops products and services that make life easier for people with very personal and private medical conditions. Working closely with the people who use our products, we create solutions that are sensitive to their special needs. We call this intimate healthcare.
Our business includes Ostomy Care, Continence Care, Wound & Skin Care, Interventional Urology and Voice & Respiratory Care. We operate globally and our organisation is about 14,000 employees.
Kristian Villumsen, President and CEO of Coloplast Group is at 25th place on the 2022 list of Top 100 Innovation Leaders.
President and Chief Executive Officer
Aurelio Alemán graduated from the University of Puerto Rico, where he obtained a bachelor’s degree in Business Administration.
His career has spanned 40 years in the finance sector, including diverse positions in management, business, credit, operations, and technology areas in institutions such as FirstBank where he started his career, and also at Citibank and Chase Manhattan Bank. He rejoined FirstBank in 1998 as Executive Vice President in charge of the consumer lending business. In October 2005 he was named COO and in 2009, he was appointed CEO.
FirstBank has approximately 700,000 customers and 3,100 employees, offering full retail and commercial banking services in Puerto Rico, Florida, and the Virgin Islands.
For more information about FirstBank, visit: 1firstbank.com